Position in QGEN
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$5,331,766
New position
Shares Held
133,161
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Groupe la Francaise holds $87,318,019 across 9 Diagnostics & Research names. QGEN ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
113,485 | $55,781,281 | |
| 2 | WAT |
Waters Corp /De/
|
31,009 | $9,234,480 | |
| 3 | DHR |
Danaher Corp /De/
|
34,035 | $6,453,036 | |
| 4 | QGEN |
Qiagen N.V.
This page
|
133,161 | $5,331,766 | |
| 5 | A |
Agilent Technologies, Inc.
|
39,069 | $4,453,084 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
6,461 | $3,630,371 | |
| 7 | FONR |
Fonar Corp
|
118,800 | $2,204,928 | |
| 8 | ICLR |
Icon PLC
|
1,300 | $143,858 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,331,766 | 133,161 | Shares | Defined | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||